Stocks
Arena Pharmaceuticals (ARNA) EV/EBITDA US GAAP (year values) |
||||||||
| FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | LTM ? | |||
| EV/EBITDA | ? | 2.29 | -11.1 | 3.21 | -7.95 | -7.53 | -8.52 | |
| Changes by years, y/y, % | -40% | -583% | -129% | -347% | -5% | |||
Arena Pharmaceuticals. EV/EBITDA
Arena Pharmaceuticals. EV/EBITDA, changes, %
Arena Pharmaceuticals (ARNA) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2020Q4 | FY2021Q1 | FY2021Q2 | FY2021Q3 | FY2021Q4 | LTM ? | |||
| EV/EBITDA | ? | -8.63 | -7.47 | -6.75 | -5.06 | -8.52 | -8.52 | |
| Changes by years, y/y, % | -381% | +73% | +4% | -43% | -1% | |||
| Changes by quarters, q/q, % | -2% | -13% | -10% | -25% | +69% | |||
